Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
about
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.Comparison of standard 1.5 T vs. 3 T optimized protocols in patients treated with glatiramer acetate. A serial MRI pilot study.An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis.Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment
P2860
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interferon beta treatment for ...... ng to their size and pathology
@ast
Interferon beta treatment for ...... ng to their size and pathology
@en
type
label
Interferon beta treatment for ...... ng to their size and pathology
@ast
Interferon beta treatment for ...... ng to their size and pathology
@en
prefLabel
Interferon beta treatment for ...... ng to their size and pathology
@ast
Interferon beta treatment for ...... ng to their size and pathology
@en
P2093
P356
P1476
Interferon beta treatment for ...... ng to their size and pathology
@en
P2093
Bastianello S
Gasperini C
Horsfield MA
Martinelli V
Pozzilli C
Prandini F
P304
P356
10.1136/JNNP.67.3.386
P407
P577
1999-09-01T00:00:00Z